Sotera Health - SHC Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sotera Health in the last year. There are currently 2 sell ratings, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SHC, but not buy additional shares or sell existing shares.
View SHC analyst ratings or view top-rated stocks.

9 brokerages have issued 1-year target prices for Sotera Health's shares. Their SHC share price forecasts range from $6.00 to $30.00. On average, they expect the company's share price to reach $15.89 in the next year. This suggests a possible upside of 90.7% from the stock's current price.
View analysts price targets for SHC or view top-rated stocks among Wall Street analysts.

Sotera Health's stock was trading at $23.55 at the start of the year. Since then, SHC stock has decreased by 64.6% and is now trading at $8.33.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our SHC earnings forecast.

Sotera Health (NYSE:SHC) posted its earnings results on Wednesday, November, 10th. The company reported $0.21 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.02. The business had revenue of $226.16 million for the quarter, compared to analysts' expectations of $222.55 million. Sotera Health had a trailing twelve-month return on equity of 40.42% and a net margin of 12.30%.

Sotera Health updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of $0.91-$0.95 for the period, compared to the consensus earnings per share estimate of $0.96. The company issued revenue guidance of $995.00M-$1.00 billion, compared to the consensus revenue estimate of $1.01 billion.

(SHC) raised $1 billion in an IPO on Friday, November 20th 2020. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup and RBC Capital Markets served as the underwriters for the IPO and BNP Paribas, Keybanc Capital Markets, Citizens Capital Markets and ING were co-managers.

Sotera Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "SHC."

Sotera Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.32%), Vanguard Group Inc. (3.26%), Boston Partners (1.10%), State Street Corp (0.91%), Reinhart Partners Inc. (0.49%) and Cubist Systematic Strategies LLC (0.49%). Insiders that own company stock include Matthew J Klaben, Michael B Jr Petras, Michael P Rutz and Pincus & Co Warburg.
View institutional ownership trends.

Shares of SHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SHC stock can currently be purchased for approximately $8.33.

Sotera Health (NYSE:SHC) has a market capitalization of $2.35 billion and generates $931.48 million in revenue each year. The company earns $116.88 million in net income (profit) each year or $0.44 on an earnings per share basis.

The company employs 3,000 workers across the globe.

Sotera Health's mailing address is 9100 SOUTH HILLS BLVD SUITE 300, BROADVIEW HEIGHTS OH, 44147. The official website for the company is www.soterahealth.com. The company can be reached via phone at 440-262-1410 or via email at ir@soterahealth.com.